跳到主要导航
跳到搜索
跳到主要内容
Pure University (For Demo Only) 国内
帮助和常见问题
English
中文
国内
简介
研究单位
科研成果
设备
数据集
活动
奖项
影响
项目
新闻 / 媒体
按专业知识、名称或附属进行搜索
联系专家
查看 Scopus 资料
Cox Jafna L.
Professor
Dalhousie University
,
Veterinary
电子邮件
CJ439814
dal
ca
网站
https://www.scopus.com/authid/detail.url?authorId=57191439814
h-index
h10-index
h5-index
8624
引用
39
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
1697
引用
14
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
843
引用
9
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
1985 …
2023
每年的科研成果
综述
指纹
网络
科研成果
(146)
相似简介
(6)
指纹
深入其中 Cox Jafna L. 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Medicine and Dentistry
Atrial Fibrillation
100%
Cardiovascular System
85%
Apoplexy
47%
Acute Heart Infarction
47%
Primary Health Care
38%
Acute Coronary Syndrome
36%
Drug Therapy
30%
Cardiovascular Disease
28%
Antithrombotic
27%
Heart Failure
24%
Health Care
22%
Anticoagulation
19%
Warfarin
17%
Congestive Heart Failure
17%
Disease
17%
Health Care Cost
17%
Coronary Artery Bypass Graft Surgery
15%
Prematurity
15%
Statin
14%
Group Therapy
14%
Myocardial Infarction
13%
Diabetes
13%
ACE Inhibitor
12%
Cardiovascular Risk
12%
Clinical Trial
12%
Hazard Ratio
12%
Health Outcomes
12%
Revascularization
12%
Primary Prevention
11%
Evidence-Based Medicine
11%
Cohort Analysis
10%
Antithrombotic Therapy
10%
Coronary Artery Disease
10%
Cluster Randomized Trial
10%
Cardiac Catheterization
9%
Cardiac Care
9%
Implantable Automatic Defibrillator
9%
Anemia
9%
Fibrinolytic Therapy
9%
Disease Management
9%
Observational Study
8%
Symptom
8%
Primary Percutaneous Coronary Intervention
8%
Ischemic Heart Disease
8%
Anticoagulant
8%
Bypass Surgery
7%
Outpatient
7%
Percutaneous Coronary Intervention
7%
Mortality Rate
7%
Clinical Guideline
7%
Keyphrases
Atrial Fibrillation
44%
Nova Scotia
33%
Acute Myocardial Infarction
31%
Canada
27%
Hospitalization
25%
Cardiovascular Outcomes
20%
Congestive Heart Failure
14%
Quality Indicators
14%
Primary Care
14%
Canadian Cardiovascular Society
14%
Warfarin
13%
Stroke Risk
12%
Care Gap
10%
Heart Failure
10%
Myocardial Infarction
10%
Randomized Trial
10%
Disease Management
10%
Anticoagulation
9%
Confidence Interval
9%
Diabetes
9%
Cardiac Care
9%
Stroke Prevention
9%
Population Rates
9%
Community Treatment
9%
Blood Glucose
9%
Family Physicians
8%
Acute Coronary Syndrome
8%
Health Systems
7%
Cardiovascular Disease
7%
GUSTO
7%
Canadian Provinces
7%
Statins
7%
High Risk
6%
Hospitalized Patients
6%
Quebec
6%
British Columbia
6%
Primary Prevention
6%
Older Adults
6%
Patients with Diabetes
5%
Without Diabetes
5%
Non-valvular Atrial Fibrillation
5%
Drug Reimbursement
5%
Reimbursement Mechanisms
5%
Stroke Prevention in Atrial Fibrillation
5%
Use of Evidence
5%
Real-life Data
5%
Evidence-based Treatment
5%
Temporal Trends
5%
Independent Predictors of Mortality
5%
System Level
5%
Nursing and Health Professions
Atrial Fibrillation
42%
Acute Heart Infarction
38%
Practice Guideline
24%
Anticoagulant Agent
20%
Drug Therapy
16%
General Practitioner
15%
Heart Infarction
13%
Heart Failure
13%
Anticoagulation
12%
Congestive Heart Failure
11%
Coronary Artery Bypass Graft
10%
Hospital Readmission
9%
Glucose Blood Level
9%
Cardiac Care
9%
Hyperglycemia
9%
Acute Coronary Syndrome
9%
Cardiovascular Risk
9%
Heart Catheterization
9%
Percutaneous Coronary Intervention
8%
ST Segment Elevation Myocardial Infarction
8%
Reperfusion
8%
Primary Medical Care
8%
Healthcare System
7%
Cardiovascular Disease
7%
Disease Management
7%
Insulin Infusion
7%
Dipeptidyl Carboxypeptidase Inhibitor
6%
Outpatient
6%
Clinician
6%
Health Service
6%
Confidence Interval
6%
Disease
6%
Adverse Event
5%
Ischemic Heart Disease
5%
Cross-Sectional Study
5%
Bypass Surgery
5%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
5%
Fibrinolytic Agent
5%
